XML 18 R57.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Segments - Operating Results and Other Financial Information by Segment (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Jun. 30, 2012
Operating Statistics [Line Items]          
Sales $ 65,979 $ 55,370 $ 114,999 $ 107,203  
Gross profit 11,408 8,736 18,621 17,080  
Operating income (loss) 3,513 2,919 4,857 5,308  
Selling and administrative expenses 7,375 5,535 12,847 10,946  
Internal research and development expenses 243 218 548 616  
Restructuring/impairment charges   (59)   (59)  
Depreciation/amortization 993 426 1,472 831  
Capital expenditures 544 1,186 1,602 1,917  
Total assets 161,094   161,094   144,555 [1]
Medical [Member]
         
Operating Statistics [Line Items]          
Sales 34,804 28,027 62,863 55,487  
Gross profit 4,344 3,883 8,538 7,497  
Operating income (loss) 1,803 2,332 4,425 4,219  
Selling and administrative expenses 2,268 1,471 3,738 3,087  
Restructuring/impairment charges   (30)   (30)  
Depreciation/amortization 634 178 807 347  
Capital expenditures 335 214 344 233  
Total assets 97,695   97,695   51,211
CS [Member]
         
Operating Statistics [Line Items]          
Sales 14,059 12,549 26,406 25,109  
Gross profit 1,428 1,306 2,524 2,394  
Operating income (loss) 777 600 1,163 943  
Selling and administrative expenses 651 706 1,361 1,451  
Depreciation/amortization 148 134 291 264  
Capital expenditures 20 62 726 202  
Total assets 25,852   25,852   24,590
DSS [Member]
         
Operating Statistics [Line Items]          
Sales 21,402 18,476 34,608 33,763  
Gross profit 5,636 3,547 7,559 7,189  
Operating income (loss) 4,143 2,404 4,681 4,645  
Selling and administrative expenses 1,250 925 2,330 1,928  
Internal research and development expenses 243 218 548 616  
Depreciation/amortization 153 101 297 195  
Capital expenditures 132 532 256 567  
Total assets 17,220   17,220   10,912
Other Unallocated [Member]
         
Operating Statistics [Line Items]          
Operating income (loss) (3,210) (2,417) (5,412) (4,499)  
Selling and administrative expenses 3,206 2,433 5,418 4,480  
Restructuring/impairment charges   (29)   (29)  
Depreciation/amortization 58 13 77 25  
Capital expenditures 57 378 276 915  
Total assets 20,327   20,327   57,842
Eliminations [Member]
         
Operating Statistics [Line Items]          
Sales (4,286) (3,682) (8,878) (7,156)  
Total assets             
[1] (a) Derived from the Company's audited financial statements as of June 30, 2012.